Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds NOVN.
No tracked institution reports a position in NOVN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-05-26 | 1-for-10reverse |
No one on the platform has traded NOVN yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-10 | $-0.09 | $-0.44 | -388.9% |
| 2023-05-15 | $-0.32 | $-0.54 | -68.8% |
| 2023-03-15 | $-0.31 | $-0.44 | -41.9% |
| 2022-11-14 | $-0.39 | $-0.43 | -10.3% |
| 2022-08-11 | $-0.59 | $-0.44 | +25.4% |
| 2022-05-16 | $-0.57 | $-0.71 | -24.6% |
| 2022-02-22 | $-0.42 | $-0.44 | -4.8% |
| 2021-11-10 | $-0.42 | $-0.34 | +19.0% |
| $13M |
| — |
| MTPMidatech Pharma plc | $0.29 | -18.50% | $2M | — |
| NTBLNotable Labs, Ltd. | $0.25 | -27.68% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry